NEW CLINICAL DATA PRESENTED AT TRANSCATHETER CARDIOVASCULAR THERAPEUTICS 2005 SUPPORTS USE OF BIOLIMUS A9 AND BIORESORBABLE COATING
Biosensors International Group, which is listed on the Mainboard of the Singapore
Exchange is pleased to announce that key clinical data from several sources
was presented at the Transcatheter Cardiovascular Therapeutics 2005 (TCT) supporting
the use of its proprietary antirestinosis drug Biolimus A9 and bioresorbable
polymer coating on new drug-eluting stent (DES) platforms.